2238 Dalakas, Marinos - Thomas Jefferson University - Thomas Jefferson University

Marinos C. Dalakas, MD, FAAN

Contact Dr. Dalakas

901 Walnut Street
4th Floor
Philadelphia, PA 19107

(215) 955 -7865
(215) 955-9976 fax

Most Recent Peer-reviewed Publications

  1. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase
  2. Pathogenesis of immune-mediated neuropathies
  3. IVIg in the chronic management of myasthenia gravis: Is it enough for your money?
  4. Mechanistic effects of IVIg in neuroinflammatory diseases: Conclusions based on clinicopathologic correlations
  5. Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?
  6. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.
  7. The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study
  8. Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives
  9. Immunology of stiff person syndrome and other GAD-associated neurological disorders
  10. Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome
  11. Novel future therapeutic options in Myasthenia Gravis
  12. Pathophysiology of autoimmune polyneuropathies
  13. Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis
  14. Vigorimeter grip strength in CIDP: A responsive tool that rapidly measures the effect of IVIG - the ICE study
  15. Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins
  16. Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients
  17. Fatigue-Related Gene Networks Identified in CD14+ Cells Isolated From HIV-Infected Patients-Part I: Research Findings
  18. Fatigue-Related Gene Networks Identified in CD14+ Cells Isolated From HIV-Infected Patients-Part II: Statistical Analysis
  19. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and β-amyloid in the muscle
  20. Biologics and other novel approaches as new therapeutic options in myasthenia gravis: A view to the future